Bifogade filer
The Nomination Committee proposes Isabelle Ducellier as a new board member of Lyko Group AB
Isabelle Ducellier
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Ahead of the Annual General Meeting on April 28, 2025, the Nomination Committee of Lyko Group AB proposes the re-election of current board members Kenneth Bengtsson, Rickard Lyko, Marie Nygren, Erika Lyko, Håkan Håkansson, and Carl-Mikael Lindholm. Additionally, the committee proposes the election of Isabelle Ducellier as a new board member and the re-election of Kenneth Bengtsson as Chairman of the Board.
Isabelle Ducellier, born in 1968, is an internationally experienced business leader with a strong track record as CEO of both publicly listed and major companies, most recently at Orkla Health. Her previous roles include CEO of BioGaia and Pernod Ricard Sweden. She has also served as Secretary General of the Swedish Childhood Cancer Foundation and as an Associate Partner at McKinsey. Originally from France, Isabelle has lived and worked in multiple countries throughout her career. She brings an international perspective and a deep understanding of cultural and business dynamics across Lyko’s markets. She is widely recognized for her strong business acumen, as well as her expertise in brand building and expansion.
With extensive experience as a CEO, she combines strategic vision with operational insight—an asset for Lyko’s continued growth journey. Her solid board experience, including her role as a board member at Björn Borg AB, provides her with a deep understanding of governance and board responsibilities. Beyond her business expertise, the Nomination Committee has been impressed by Isabelle’s dynamic personality, strong drive, and high energy. The committee is confident that her boldness and commitment will positively contribute to the board’s dynamics and decision-making.
Education: Master’s degree in Business Administration from Emlyon Business School, Executive MBA from Harvard Business School.
Previous positions: CEO of Orkla Health, BioGaia, and Pernod Ricard Sweden, Secretary General of the Swedish Childhood Cancer Foundation, Associate Partner at McKinsey, Board member of Björn Borg AB
Shareholding in the company:-
Independence: Independent of the company and its management, independent of the company’s major shareholders
The Nomination Committee’s other proposals and its reasoned statement will be presented in conjunction with the notice of the 2025 Annual General Meeting.
The Nomination Committee for the 2025 AGM consists of: Stefan Lyko (appointed by Lyko Holding AB), Alexandra Björklund (appointed by Fidelio Capital AB), Carl-Mikael Lindholm (appointed by the Hamrin family), Celia Grip (appointed by Swedbank Robur Fonder), Kenneth Bengtsson (Chairman of the Board)